The new hire’s background includes CFO roles at several biotech firms acquired in high-profile deals, such as Sirna Therapeutics (acquired by Merck) and ILEX Oncology (acquired by Genzyme).
The 16 restaurants in the deal represent a “significant incremental addition” to the 45 total franchised restaurants the company has acquired across six transactions since May 2023.
Earnings per share (EPS) came in at $0.15, above consensus estimates of $0.12. Revenues stood at $937.1 million, 0.07% estimated by analysts.
Citi, JPMorgan, and Piper Sandler have upgraded their ratings and raised their price targets on Upstart.
NuScale sees strong future potential as increasing interest in nuclear power aligns with US policy changes under Trump’s administration.
Aurinia plans to slash 45% of its entire workforce with an aim to save more than $40 million in annual operating expenses.
CEO Josh Charlesworth expressed optimism about the company’s streamlined approach, emphasizing a focus on profitable U.S. expansion and a franchise-centered model.
Retail sentiment on the stock climbed to ‘extremely bullish’ (94/100) from ‘bullish’ (64/100)a day ago.
It's time to invest in small caps.
Amid a sector rotation into small-caps, Morgan Stanley is bullish on growth names ahead of the Fed's expected policy shift. Here's a look at three ETFs that can benefit.